178 related articles for article (PubMed ID: 17610477)
1. Gastric adenocarcinoma with chief cell differentiation.
Tsukamoto T; Yokoi T; Maruta S; Kitamura M; Yamamoto T; Ban H; Tatematsu M
Pathol Int; 2007 Aug; 57(8):517-22. PubMed ID: 17610477
[TBL] [Abstract][Full Text] [Related]
2. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma.
Singhi AD; Lazenby AJ; Montgomery EA
Am J Surg Pathol; 2012 Jul; 36(7):1030-5. PubMed ID: 22472957
[TBL] [Abstract][Full Text] [Related]
3. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma.
Ueyama H; Yao T; Nakashima Y; Hirakawa K; Oshiro Y; Hirahashi M; Iwashita A; Watanabe S
Am J Surg Pathol; 2010 May; 34(5):609-19. PubMed ID: 20410811
[TBL] [Abstract][Full Text] [Related]
4. Chief cell hyperplasia with structural and nuclear atypia: a variant of fundic gland polyp.
Matsukawa A; Kurano R; Takemoto T; Kagayama M; Ito T
Pathol Res Pract; 2005; 200(11-12):817-21. PubMed ID: 15792126
[TBL] [Abstract][Full Text] [Related]
5. Well differentiated adenocarcinoma of the stomach composed of chief cell-like cells and parietal cells (Gastric adenocarcinoma of fundic gland type).
Terada T
Int J Clin Exp Pathol; 2011; 4(8):797-8. PubMed ID: 22135729
[TBL] [Abstract][Full Text] [Related]
6. A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohistochemical and ultrastructural study.
Yamazaki K
Virchows Arch; 2003 Jan; 442(1):77-81. PubMed ID: 12536318
[TBL] [Abstract][Full Text] [Related]
7. Gastric adenocarcinoma of fundic gland type (chief cell predominant type) treated with endoscopic aspiration mucosectomy.
Fukatsu H; Miyoshi H; Ishiki K; Tamura M; Yao T
Dig Endosc; 2011 Jul; 23(3):244-6. PubMed ID: 21699569
[TBL] [Abstract][Full Text] [Related]
8. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: A case report.
Liu L; Han L; Ma Q; Zhang J
Medicine (Baltimore); 2021 May; 100(21):e25861. PubMed ID: 34032698
[TBL] [Abstract][Full Text] [Related]
9. Esophageal gland duct adenoma: immunohistochemical comparison with the normal esophageal gland and ultrastractural analysis.
Harada O; Ota H; Katsuyama T; Hidaka E; Ishizaka K; Nakayama J
Am J Surg Pathol; 2007 Mar; 31(3):469-75. PubMed ID: 17325490
[TBL] [Abstract][Full Text] [Related]
10. Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma.
Kushima R; Sekine S; Matsubara A; Taniguchi H; Ikegami M; Tsuda H
Pathol Int; 2013 Jun; 63(6):318-25. PubMed ID: 23782334
[TBL] [Abstract][Full Text] [Related]
11. Synchronous primary gastric mantle cell lymphoma and early gastric carcinoma: a case report.
Chong Y; Shin JJ; Cho MY; Cui Y; Kim HY; Park KH
Pathol Res Pract; 2008; 204(6):407-11. PubMed ID: 18282664
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation of periodic-acid Schiff and Alcian blue-negative signet-ring cell-like cells and tubular adenocarcinoma cells within a gastric cancer.
Sugihara A; Nakasho K; Yamada N; Nakagomi N; Tsujimura T; Terada N; Tsuji M
Scand J Gastroenterol; 2004 Aug; 39(8):795-800. PubMed ID: 15513370
[TBL] [Abstract][Full Text] [Related]
13. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
14. STAT3 as a prognostic marker in human gastric cancer.
Jackson CB; Giraud AS
J Gastroenterol Hepatol; 2009 Apr; 24(4):505-7. PubMed ID: 19368630
[No Abstract] [Full Text] [Related]
15. RUNX3 expression correlates with chief cell differentiation in human gastric cancers.
Ogasawara N; Tsukamoto T; Mizoshita T; Inada KI; Ban H; Kondo S; Takasu S; Ushijima T; Ito K; Ito Y; Ichinose M; Ogawa T; Joh T; Tatematsu M
Histol Histopathol; 2009 Jan; 24(1):31-40. PubMed ID: 19012242
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of gastric adenocarcinoma with chief cell differentiation using upper gastrointestinal tract endoscopy.
Abe T; Nagai T; Fukunaga J; Okawara H; Nakashima H; Syutou M; Kajimoto N; Wake R; Oyama T; Yao T
Intern Med; 2013; 52(14):1585-8. PubMed ID: 23857090
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach?
Maeda H; Okabayashi T; Nishimori I; Sugimoto T; Namikawa T; Dabanaka K; Tsujii S; Onishi S; Kobayashi M; Hanazaki K
J Am Coll Surg; 2008 Feb; 206(2):306-10. PubMed ID: 18222384
[TBL] [Abstract][Full Text] [Related]
18. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness.
Han HS; Lee SY; Lee KY; Hong SN; Kim JH; Sung IK; Park HS; Jin CJ; Min YI
J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
20. Extremely well-differentiated adenocarcinoma of the gastric cardia: a unique case with columnar cells and laminated stones.
Nokubi M; Kawanowa K; Kawata H; Hanatsuka K; Hosoya Y
Pathol Int; 2004 Nov; 54(11):854-60. PubMed ID: 15533229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
